ArticleJournal of Cancer2020

Optimal timing of antiviral therapy for patients with malignant tumor who presented with hepatitis B reactivation during chemotherapy and/or immunosuppressive therapy.

Xiaofang Zou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.